Mounjaro

Six months in.

You’\”ve done your first tirzepatide injection. The starter dose is 2.5 mg, the side effects have shown up, and the scale has moved a little.

Twelve weeks on tirzepatide. You’\”ve cleared three titrations, you’\”re wrapping up the 7.5 mg cycle, and the trajectory is now clear.

Eight weeks on tirzepatide.

A full year of tirzepatide. Fifty-two weekly injections, multiple dose adjustments, behavioral resets, and a slow but real shift in baseline.

Four weeks of tirzepatide. You’\”re about to move from 2.5 mg to 5 mg, which is where the drug starts doing meaningful work.

Tirzepatide can cause acute pancreatitis, though rates in the SURMOUNT-1 trial (Jastreboff et al.

Introduction Tirzepatide is a dual agonist that activates two different gut hormone receptors at the same time: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like…

Yes. Tirzepatide is FDA-approved for chronic use in both type 2 diabetes (Mounjaro) and obesity (Zepbound).